METHOD FOR DETERMINING DEGREE OF SEVERITY OF AGGRAVATED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FOR SPECIFYING OPTIMAL APPROACH TO PATIENT MANAGEMENT Russian patent published in 2012 - IPC A61B5/08 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to therapy and pulmonology. Anamnestic data and objective examination methods are used to derive points. Breathing rate 30 and more requires assigning 2 points, and breathing rate less than 30 and more than 19 requires assigning 1 point, and if it does not exceed 10, 0 points is assigned. Number of aggravated COPDs being 3 and more, 1 point is assigned, while 0 points is assigned if stating less than 3 aggravations of COPD. If sleep apnea syndrome is present, 1 point is assigned, and if it is absent, 0 points is assigned, The presence of underlying diseases - 1 point, the absence - 0 points. The patient's age of 60 years old and more - one point, less than 60 years old - 0 points. Oriental status with underlying aggravated COPD - if the patient does not answer the questions, shows no response on noxious stimuli - 2 points, if the patient is disoriented or gibbers, executes no commands - 1 point; if the patient is oriented and can answer the questions and executes the commands - 0 points is added. The points are summed up. If total score is 1 point and less, slightly aggravated COBD is diagnosed, and out-patient treatment with the use of a base therapy is recommended. Total score 2-3 points enables diagnosing a moderate degree of aggravation, admission of the patient to specialised department is considered to be needed and require the base therapy, systemic glucocorticosteroids, antibacterial preparations and parenteral introduction of drugs to be prescribed Total score 4 points and more provides diagnosing severe aggravation of COBD with stating a necessity of admission to an intensive care unit added with the use of oxygen-therapy, non-invasive or invasive pulmonary ventilation.

EFFECT: method extends the range of products for determining a degree of severity of aggravated chronic obstructive pulmonary disease (COPD) for specifying optimal approach to patient management.

1 tbl, 2 ex